Efficacy and Neurotoxicity of ARA-AMP in CAH-B
First published: April 1990
No abstract is available for this article.
References
- 1
Marcellin P,
Ouzan D,
Degos F,
Brechot C,
Metman EH,
Degott C,
Chevalier M, et al.
Randomized controlled trial of adenine arabinoside 5' -monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
HEPATOLOGY
1989;
10:
328–331.
- 2
Lok ASF,
Novick DM,
Karayiannis P,
Dunk AA,
Sherlock S,
Thomas HC.
A randomized study of the effects of adenine arabinoside 5' -monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
HEPATOLOGY
1985;
5:
1132–8.
- 3
Novick DM,
Lok ASF,
Thomas HC.
Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
J Hepatol
1984;
1:
29–35.
- 4
Hoofnagle JH,
Peters M,
Mullen KD,
Jones DB,
Rustgi V,
DiBisceglie A,
Hallahan C, et al.
Randomized controlled trial of recombinant human α-interferon in patients with chronic hepatitis B.
Gastroenterology
1988;
95:
1318–25.
- 5
Scullard GH,
Pollard RB,
Smith JL,
Sacks SL,
Gregory PB,
Robinson WS,
Merigan TC.
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
J Infect Dis
1981;
143:
772–783.
- 6
Lok ASF,
Wilson LA,
Thomas HC.
Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection.
J Antimicrob Chemother
1984;
14:
93–9.
